Colistimethate Sodium
Who holds supplier records for Colistimethate Sodium? 4 organisations hold a current record for Colistimethate Sodium: an active US FDA Type II Drug Master File or a CEP. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2) and Denmark (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Colistimethate Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/colistimethate-sodium
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in China
2 of the 3 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Colistimethate Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTDCEP Company GMP cert on recordActive DMF 28350 · latest filing May 2014
- Xellia PharmaceuticalsDenmarkCEP Company GMP cert on recordActive DMF 13363 · latest filing Sept 1998
- Hebei Shengxue Dacheng Pharmaceutical Co. Ltd.ChinaActive DMF 35177 · latest filing Sept 2020
- ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Colistimethate Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO., LTD. Fuzhou | CN | CEP 2018-085 - Rev 06 Colistimethate sodium | Jul 2025 | Inspected Apr 2025 Germany |
| LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. Lianyungang | CN | CEP 2015-189 - Rev 01 Colistimethate sodium | Jul 2025 | — |
| XELLIA PHARMACEUTICALS APS Copenhagen S | DK | R1-CEP 2000-207 - Rev 06 Colistimethate sodium, Sterile | Apr 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Overview
Colistimethate Sodium is a unknown active pharmaceutical ingredient (ChEMBL CHEMBL1201441).
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Polymyxin-class Antibacterial
- Chemical structure
- Polymyxins
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Colistimethate Sodium?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Colistimethate Sodium: LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTD, Xellia Pharmaceuticals (Denmark), Hebei Shengxue Dacheng Pharmaceutical Co. Ltd. (China) and LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Colistimethate Sodium Drug Master Files are active?
LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTD (DMF 28350), Xellia Pharmaceuticals (DMF 13363) and Hebei Shengxue Dacheng Pharmaceutical Co. Ltd. (DMF 35177). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Colistimethate Sodium have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Colistimethate Sodium on the EDQM register, including LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO., LTD. Fuzhou (CN), LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. Lianyungang (CN) and XELLIA PHARMACEUTICALS APS Copenhagen S (DK). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Colistimethate Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Colistimethate Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.